This is a Validated Antibody Database (VAD) review about mouse Klrc1, based on 18 published articles (read how Labome selects the articles), using Klrc1 antibody in all methods. It is aimed to help Labome visitors find the most suited Klrc1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Klrc1 synonym: CD159a; NKG2A; NKG2B
Invitrogen
mouse monoclonal (16A11) |
| Invitrogen Klrc1 antibody (eBioscience, 16a11) was used in flow cytometry on mouse samples (fig 2a). Nature (2020) ncbi |
rat monoclonal (20d5) |
| Invitrogen Klrc1 antibody (eBioscience, 11-5896-82) was used in flow cytometry on mouse samples at 1:100 (fig 5). elife (2018) ncbi |
mouse monoclonal (16A11) |
| Invitrogen Klrc1 antibody (eBioscience, 16a11) was used in flow cytometry on mouse samples (fig 6e). J Exp Med (2019) ncbi |
mouse monoclonal (16A11) |
| In order to investigate the important of Ly49A ITIM signaling in NK-cell effector inhibition, licensing, and receptor repertoire development, Invitrogen Klrc1 antibody (eBiosciences, 16a11) was used in flow cytometry on mouse samples (fig 4a). Proc Natl Acad Sci U S A (2017) ncbi |
rat monoclonal (20d5) |
| In order to determine the function of the SLAM family of proteins in natural killer cells, Invitrogen Klrc1 antibody (eBioscience, 20d5) was used in flow cytometry on mouse samples (fig 2). J Exp Med (2016) ncbi |
rat monoclonal (20d5) |
| Invitrogen Klrc1 antibody (eBioscience, 20d5) was used in flow cytometry on mouse samples (fig s2b). Immunity (2016) ncbi |
rat monoclonal (20d5) |
| In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen Klrc1 antibody (eBioscience, 20d5) was used in flow cytometry on mouse samples at 1:100 (fig s4). Nat Commun (2016) ncbi |
rat monoclonal (20d5) |
| Invitrogen Klrc1 antibody (eBioscience, 20D5) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2015) ncbi |
BioLegend
mouse monoclonal (16A11) |
| BioLegend Klrc1 antibody (Biolegend, 142809) was used in flow cytometry on mouse samples at 1:100 (fig 3d). Development (2022) ncbi |
mouse monoclonal (16A11) |
| BioLegend Klrc1 antibody (Biolegend, 16A11) was used in flow cytometry on mouse samples (fig 3d). J Immunother Cancer (2021) ncbi |
mouse monoclonal (16A11) |
| BioLegend Klrc1 antibody (BioLegend, 16A11) was used in flow cytometry on mouse samples (fig 5b). Nat Commun (2016) ncbi |
Miltenyi Biotec
rat monoclonal (20d5) |
| Miltenyi Biotec Klrc1 antibody (Miltenyi Biotec, 130-105-619) was used in immunohistochemistry - frozen section on mouse samples (fig s6). Sci Rep (2022) ncbi |
rat monoclonal (20d5) |
| Miltenyi Biotec Klrc1 antibody (Miltenyi Biotec, 130-105-566) was used in flow cytometry on mouse samples (fig 2a, 3a). Cell (2018) ncbi |
BD Biosciences
rat monoclonal (20d5) |
| BD Biosciences Klrc1 antibody (BD Biosciences, 20d5) was used in flow cytometry on mouse samples (fig 2a). Nature (2020) ncbi |
rat monoclonal (20d5) |
| BD Biosciences Klrc1 antibody (BD, 20d5) was used in flow cytometry on mouse samples (fig 6a). J Immunol (2018) ncbi |
rat monoclonal (20d5) |
| In order to find an alternative pathway of NK-cell development driven by IL-12, BD Biosciences Klrc1 antibody (BD Biosciences, 20d5) was used in flow cytometry on mouse samples at 1:100 (fig 3d). Nat Commun (2016) ncbi |
rat monoclonal (20d5) |
| In order to investigate the ability of PTEN to regulate natural killer cell function, BD Biosciences Klrc1 antibody (BD Biosciences, 20d5) was used in flow cytometry on mouse samples (fig 3d). J Immunol (2015) ncbi |
rat monoclonal (20d5) |
| BD Biosciences Klrc1 antibody (BD Pharmingen, 20d5) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi |
rat monoclonal (20d5) |
| BD Biosciences Klrc1 antibody (BD Biosciences, 20d5) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi |
Articles Reviewed
- Brownlie D, Doughty Shenton D, Yh Soong D, Nixon C, O Carragher N, M Carlin L, et al. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β. J Immunother Cancer. 2021;9: pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments